Results
1 -
10 of
95Systemische Therapie maligner Nebennierentumoren, Der Urologe Cytotoxicity and decreased corticosterone production in adrenocortical Y-1 cells by 3-methylsulfonyl-DDE and structurally related molecules, Archives of Toxicology Adrenocortical Carcinoma: Surgery and Mitotane for Treatment and Steroid Profiles for Follow-up, World Journal of Surgery Residues of O,Pu2032-DDD and O,Pu2032-DDT in brown pelican eggs and mallard ducks, Bulletin of Environmental Contamination and Toxicology Journal of Endocrinological Investigation.
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma, Journal of Endocrinological Investigation No evidence for relevant QT interval prolongation in mitotane-treated patients with adrenocortical carcinoma, Journal of Endocrinological Investigation Chemotherapy of Adrenal Cortical Carcinoma, Chemotherapy and Urological Malignancy Mitotane, Adrenocortical Carcinoma Nebennierenrindenkarzinom, Kompendium Internistische Onkologie The History of Adrenocortical Carcinoma Treatment ? A Medical Perspective, Adrenocortical Carcinoma